Digestive and Metabolic Emergence: Slow-Wave Transport, Peristalsis, and the Glucose Homeostat
This volume emerges the digestive organs and their dynamics on the shared VP jamming substrate: the gastric slow-wave pacemaker, the aboral frequency gradient, peristaltic transport, the glucose–insulin homeostat, glucagon counter-regulation, and a single carcinogen barrier-Kramers kernel instantiated for three organ sites — then perturbed into eight disease sections (gastric dysrhythmia + gastroparesis, the type 1/type 2 diabetes spectrum, gastritis + peptic ulcer, the intestinal motility / transit disorders, a group of scattered Tier-1 perturbations — dumping, reflux oesophagitis, insulinoma/reactive hypoglycaemia, functional dyspepsia and SIBO — the sphincter-gate disorders on the first Tier-2 primitive, a tonically-closed R19 gate giving GERD and achalasia as two opposite failures of one gate, the gastric accommodation reservoir on the second Tier-2 primitive, an R19 fundic-wall stiffness whose impaired relaxation raises meal pressure prematurely to give functional dyspepsia / post-prandial distress, and the visceral afferent gain on the third Tier-2 primitive — the R19 element’s susceptibility, the same curvature the reservoir reads as compliance — giving the IBS subtypes and functional abdominal pain) — then the carcinogen kernel is extended to more sites in the §19–§21 neoplastic sections (a Barrett’s / gastric-Correa metaplasia precursor step read as a discrete rate-limiting compartment, the HBV×aflatoxin and smoking×alcohol synergies generalizing the §10 interaction with a falsifiable sub-multiplicative prediction, and reversible H. pylori MALT plus single-driver HPV anal carcinoma with an honestly-stated out-of-kernel boundary), and finally five Tier-3 sections add the first cross-system primitives, each on one new R19-derived element (the §22 immune relapsing-inflammation layer — inflammatory bowel disease as a self-sustaining R19 flare basin whose hysteresis forces the induction≠maintenance asymmetry, bridged to the §7 barrier so colitis cancer rises to the cited anchor and reverses on remission, with celiac in the antigen-dependent regime — the §23 exocrine autodigestion layer — acute pancreatitis as an autocatalytic switch latching irreversibly past threshold, pre-threshold-only, with large-reserve exocrine insufficiency and PERT rescue as the chronic mirror — the §24 perfusion / vascular layer — a perfusion-viability switch giving chronic mesenteric ischaemia as a demand-driven margin collapse and acute ischaemia / ischaemic colitis as a forced flip with a time-critical salvage window, with NAFLD/MASLD reusing the §12 homeostat and the lipid layer a circulatory seam — the §25 hepatobiliary / bile layer — a nucleation barrier giving cholelithiasis as metastable supersaturation with dissolution hysteresis (UDCA only on small early stones), the stasis / cholecystitis arms cited to the B1 gate and C1 flare — and the §26 structural / mechanical layer — a Laplace wall-mechanics switch giving diverticular disease as herniation past P = tension/radius, fibre treatment the geometry in reverse, with diverticulitis the cited C1 flare and the fixed-block obstructions the §14 functional-module counterpart), each phenotype emerging rather than fitted — and finally a cross-system seam section (§27) wires the declared circulatory and mind seams citation/pointer-only (the circulatory hepatic interface Q_H = 1500 mL/min / E = 0.75 / F = 0.25 consumed as the NAFLD/MASLD and bile delivery substrate, the mind felt-symptom seam a one-way pointer) behind a firewall enforced by an architectural lock (zero sibling imports; a metabolic state with no felt/HPA key). Headline results: gastric ~3 cpm → duodenum 11.1 cpm (one clock) ; glucose load → 5 mM setpoint ; RR(dose) = rate(dose)/rate(0) ; one homeostat → type 1 (capacity) + type 2 (gain) diabetes ; one ICC lesion → gastroparesis + slow-transit + pseudo-obstruction ; fast carbohydrate delivery → dumping/reactive-hypoglycaemia crossing (one loop) ; one gate, two failures: GERD (reflux) ↔ achalasia (stasis) ; stiff fundic reservoir → premature meal pressure (functional dyspepsia, post-prandial distress) ; one R19 curvature, two readings: afferent gain (IBS hypersensitivity) = fundic compliance ; barrier continuum reaches cancer: Barrett's/Correa metaplasia (rate-limiting precursor) + HBV×aflatoxin / smoke×alcohol synergy + reversible H. pylori MALT ; self-sustaining basins: IBD relapse hysteresis (induction≠maintenance) + colitis→barrier→cancer bridge, and acute-pancreatitis autocatalytic latch (irreversible past threshold) ; physics of the wall and the fluid: mesenteric-ischaemia supply−demand flip (time-critical salvage window) + gallstone nucleation barrier (UDCA only on small early stones) + diverticular Laplace herniation (fibre reverses the geometry) ; cross-system seams wired (citation/pointer-only, no sibling import): circulatory hepatic interface (Q_H=1500 mL/min, E=0.75, F=0.25) consumed as the NAFLD/MASLD + bile delivery substrate, the mind felt-symptom seam a one-way pointer, the firewall an architectural lock (0 sibling imports; metabolic state mind-free) ; analgesic target logic INHERITED (analgesic_threshold_logic v2.0, DOI 10.5281/zenodo.20733420): 27 non-opioid pain targets re-derive on this package's own §18 afferent spinodal (drift 0) — three drug-class levers (reduce inward current / open K_V7 / remove NGF-CGRP drive), each raising the §18 firing threshold, a cited-drug-class pointer for IBS / functional abdominal pain / biliary colic / oesophageal-spasm pain (every clinical magnitude + the felt pain [O], firewall held) ; in-substrate Tier-1 surface CLOSED (§29, no new primitive): dyssynergic defecation (§16 gate at the anorectal outlet) + Hirschsprung (§4 segmental aganglionic block, proximal dilatation) + MODY (a distinct regulated §12 curve) + hepatic GSD-I (§6 fasting hypoglycaemia + failed counter-reg) + autoimmune gastritis (§22 corpus flare, achlorhydria) — three monogenic items gene-key → disease_wp ; live cross-package harness (§30, OUT OF GATE): loads every VP volume in one process and confirms against the LIVE sibling engines the identities the seams took on trust — shared R19 substrate drift 0, circulatory's live hepatic_clearance() reproducing the vendored snapshot, the 27-target analgesic map re-deriving through every volume's spinodal, and the neuro nociceptor (Na_V1.7/SCN9A, master PRDM12) the §18→mind pointer targets on the shared substrate; verify-alone preserved (build sibling-free; engines loaded by file path, not imported), harness digest sibling-independent.
This package derives on the VP jamming substrate → VP Theory (physics). Organ identity and developmental order are cited from the DNA morphogenesis gene-clock (measured γ, grade [V]); the low-frequency oscillator mechanism is cited from the neural emergence chain. This package adds only the functional dynamics and the carcinogen dose-response.
- §1 Organ emergence from measured γ[V] simulation-verified
- §2 Gastric slow-wave pacemaker (~3 cpm)[V] simulation-verified
- §3 Aboral slow-wave frequency gradient[V] simulation-verified
- §4 Peristaltic aboral transport[V] simulation-verified
- §5 Glucose–insulin homeostat setpoint[V] simulation-verified
- §6 Hypoglycaemia counter-regulation[V] simulation-verified
- §7 Carcinogen barrier-Kramers kernel[F] forced
- §8 Colorectal processed-meat dose-response[V] simulation-verified
- §9 Pancreatic smoking dose-response[V] simulation-verified
- §10 Gastric H. pylori–diet synergy[V] simulation-verified
- §11 Gastric dysrhythmia and gastroparesis[V] simulation-verified
- §12 Diabetes: capacity and gain on one homeostat[V] simulation-verified
- §13 Gastritis and peptic ulcer: the barrier axis[V] simulation-verified
- §14 Intestinal motility and transit disorders[V] simulation-verified
- §15 Additional Tier-1 perturbations (dumping, reflux, insulinoma, FD, SIBO)[V] simulation-verified
- §16 Sphincter-gate disorders (GERD, achalasia, spasm, Oddi)[V] simulation-verified
- §17 Gastric accommodation reservoir (functional dyspepsia, post-prandial distress)[V] simulation-verified
- §18 Visceral afferent gain (IBS subtypes, functional abdominal pain)[V] simulation-verified
- §19 Metaplasia precursor step (Barrett's → EAC, gastric Correa cascade)[V] simulation-verified
- §20 Carcinogen synergy generalized (HCC: HBV×aflatoxin; ESCC: smoking×alcohol)[V] simulation-verified
- §21 Reversibility, single-driver, and the honest kernel boundary (MALT, anal; GIST/NET/small-bowel/cholangio)[V] simulation-verified
- §22 Immune relapsing-inflammation layer (IBD relapse hysteresis, induction/maintenance asymmetry, colitis→cancer bridge)[V] simulation-verified
- §23 Exocrine autodigestion layer (acute pancreatitis autocatalytic latch, large-reserve EPI, PERT rescue)[V] simulation-verified
- §24 Perfusion / vascular layer (mesenteric ischaemia, ischaemic colitis, NAFLD/MASLD metabolic overlap)[V] simulation-verified
- §25 Hepatobiliary / bile layer (cholelithiasis nucleation barrier, dissolution hysteresis, biliary seams)[V] simulation-verified
- §26 Structural / mechanical layer (diverticular disease Laplace wall-mechanics, fibre treatment, obstruction boundary)[V] simulation-verified
- §27 Cross-system seams (wired): circulatory hepatic delivery substrate + mind felt-symptom firewall[V] simulation-verified
- §28 Analgesic target logic for visceral pain (inherited): a DNA-grounded 27-target firing-threshold map sorted into three drug-class levers[V] simulation-verified
- §29 Remaining in-substrate perturbations (dyssynergic defecation, Hirschsprung, MODY, hepatic GSD-I, autoimmune gastritis)[V] simulation-verified
- §30 Live cross-package harness: load every VP volume in one process and verify the shared substrate, hepatic seam, analgesic map and felt-symptom endpoint against the live sibling engines (out of gate)[V] simulation-verified
Roadmap — further disease modules (future work)
The first disease modules are now built as §11–§18 (gastric dysrhythmia + gastroparesis, the type 1/type 2 diabetes spectrum, gastritis + peptic ulcer, the intestinal motility / transit disorders, and a further group of scattered Tier-1 perturbations — dumping, reflux oesophagitis, insulinoma/reactive hypoglycaemia, functional dyspepsia and SIBO), the §16 sphincter-gate disorders (GERD, achalasia, esophageal spasm, sphincter of Oddi) on the first Tier-2 primitive — a tonically-closed R19 gate — the §17 gastric accommodation reservoir (functional dyspepsia, post-prandial distress / early satiation) on the second Tier-2 primitive, the R19 wall stiffness whose compliance peaks exactly at the spinodal yield point, and the §18 visceral afferent gain (IBS-C/-D/-M and functional abdominal pain) on the third Tier-2 primitive — the R19 element’s susceptibility, the same curvature inverse the §17 reservoir reads as compliance, diverging at the same spinodal — the Tier-1 sections each perturbing one validated module and the three Tier-2 sections each adding one new R19-derived primitive, with every phenotype emerging rather than fitted. The carcinogen kernel is then extended in the §19–§21 neoplastic sections — a Barrett’s / gastric-Correa metaplasia precursor step (the same g-reduction read as a discrete, rate-limiting compartment), the HBV×aflatoxin and smoking×alcohol synergies generalizing the §10 interaction with a falsifiable sub-multiplicative prediction, and reversible H. pylori MALT plus single-driver HPV anal carcinoma alongside an honestly-stated out-of-kernel boundary. Five Tier-3 sections then add the first cross-system primitives, each on one new R19-derived element: the §22 immune relapsing-inflammation layer (inflammatory bowel disease as an R19 switch with a self-sustaining flare basin — the relapsing-remitting hysteresis forcing the induction≠maintenance dose asymmetry, and a cumulative-burden bridge that lowers the same §7 barrier scale so colitis-associated cancer rises to the cited anchor and reverses on remission, closing the §21 small-bowel boundary; celiac and the immune enteropathies share the element in its antigen-dependent regime), the §23 exocrine autodigestion layer (acute pancreatitis as an autocatalytic R19 switch whose supra-threshold trigger latches irreversibly — pre-threshold-only intervention — with the large-reserve exocrine insufficiency and PERT rescue as its chronic mirror), the §24 perfusion / vascular layer (a perfusion-viability switch with bias h = perfusion − demand giving chronic mesenteric ischaemia as a demand-driven margin collapse and acute mesenteric ischaemia / ischaemic colitis as a forced flip with a time-critical salvage window, the NAFLD/MASLD overlap reusing the §12 type-2 homeostat with the lipid layer a circulatory seam), the §25 hepatobiliary / bile layer (a nucleation barrier giving cholelithiasis as metastable supersaturation that nucleates only past the barrier and a formed stone showing dissolution hysteresis — why UDCA works only on small early stones — with the stasis / cholecystitis arms cited to the B1 gate and C1 flare), and the §26 structural / mechanical layer (a Laplace wall-mechanics switch giving diverticular disease as herniation once P = tension/radius clears the threshold, fibre treatment as the geometry in reverse, with diverticulitis the cited C1 flare and the fixed-block obstructions the §14 functional-module counterpart). A final cross-system seam section (§27) then wires the seams the §24 / §25 / §18 sections declared — citation/pointer-only, never a sibling code import: the circulatory hepatic interface (its charter SSOT) consumed as the NAFLD/MASLD and bile delivery substrate, and the mind felt-symptom seam (visceral pain, biliary colic) a one-way forward-defer pointer — behind a firewall enforced by an architectural lock (zero sibling imports; a metabolic state with no felt/HPA key), the same lock mind runs neuro-side. The §28 section then INHERITS a sibling DNA-grounded 27-target non-opioid analgesic map and reads it on this volume’s own §18 afferent spinodal (drift 0) as a cited drug-class pointer for visceral pain, and the §29 section CLOSES the in-substrate digestive Tier-1 surface by REUSE — dyssynergic defecation (the §16 gate read at the anorectal outlet), Hirschsprung (a §4 segmental aganglionic block with proximal dilatation), MODY (a targeted §12 secretory lesion giving a distinct regulated curve), hepatic GSD type I (a crippled §6 glycogen-buffer release giving fasting hypoglycaemia and failed counter-regulation) and autoimmune gastritis (the §22 flare read corpus-localised), the three monogenic items gene-key to disease_wp. The remaining digestive-tract diseases are enumerated in full — each mapped to a substrate module with a discriminant, expected grade, and obstacle — in FUTURE_WORK.md. Listed below as planned targets only (no result is claimed). Standing policy: while the program is incomplete, the remaining roadmap ships with the deliverable.
Cross-package frontier (needs the sibling packages)
propagate the §28 analgesic map to circulatory / neuro (musculoskeletal already carries it)
Sibling-owned / out-of-scope (cited, not re-emerged)
GI bleeding / varices (circulatory) · cirrhosis / viral / alcoholic hepatitis (circulatory) · megacolon (toxic / acquired), anorectal (haemorrhoids, fissure, fistula)
Canonical artifact: this HTML (VP-SPEC v1.8, C2). Every displayed number is regenerated deterministically by the in-package engine (C1, 2×sha256 identical). Open quantities carry a stated obstacle (C3); see the irreproducibility ledger. Reproduction code: GitHub repro tree.